AUPH News and Press, Aurinia Pharmaceuticals Inc From 12/02/21

Wall Street's volatile week continued on Thursday, with stocks bouncing back after their recent losses. The rebound included a strong performance from a collection of retail names, as investors found hope in a handful of earnings reports that higher costs wouldn't necessarily obliterate margi...

Shares of the autoimmune disease specialist Aurinia Pharmaceuticals (NASDAQ: AUPH) are up by a noteworthy 15.5% as of 1:10 p.m. ET Thursday afternoon. The drugmaker's stock is perking up today in response to renewed buyout speculation. Rumors began to swirl about a possible buyo...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors in Express (NYSE: EXPR ) stock are celebrating on Thursday thanks to the release of the company’s Q3 2021 earnings report. Source: Helen89 / Shutterstock.com Let’s break down that earni...

Gainers: Biofrontera (NASDAQ:BFRI) +36%. CF Acquisition (NASDAQ:CFVIU) +19%. Day One (NASDAQ:DAWN) +16%. Terns Pharmaceuticals (NASDAQ:TERN) +15%. Duluth Holdings (NASDAQ:DLTH) +15%. Snowflake (NYSE:SNOW) +14%. Aurinia Pharmaceuticals (NASDAQ:AUPH) +14%. Express (NYSE:EXPR) +13%. Vor Biopharm...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biofrontera (NASDAQ: BFRI ) stock is getting a boost on Thursday thanks to an update from the United States Patent and Trademark Office (USPTO). Source: Bukhta Yurii / Shutterstock.com According to a news rele...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aurinia Pharma (NASDAQ: AUPH ) stock is on the rise Thursday as investors hold out hope for a takeover of the company. Source: Shutterstock.com The most recent reports claim that Novartis (NYSE: NVS ) co...

A newly detected coronavirus variant in Africa created panic and sparked a market selloff in the holiday-shortened week. However, the developers of COVID-19 vaccines and therapeutics advanced while several common stock offerings pressured decliners. Despite the outperformance of biotech stock...

Gainers: Pasithea Therapeutics (NASDAQ:KTTA) +257%, Petros Pharmaceuticals (NASDAQ:PTPI) +73%, Gracell Biotechnologies (NASDAQ:GRCL) +64%, iSpecimen (NASDAQ:ISPC) +43%, Qualigen Therapeutics (NASDAQ:QLGN) +33%. Losers: Longeveron (NASDAQ:LGVN) -36%...

On a day when the Nasdaq and S&P 500 lost ground, oil stocks represented a rare bright spot on Monday. The sector climbed as the U.S. and OPEC+ squared off over crude supplies. ConocoPhillips (NYSE:COP), Diamondback Energy (NASDAQ:FANG), Occidental Petroleum (NYSE:OXY), Phillips 66 (NYSE:...

The last few weeks have seen a lot of buyout chatter on AUPH. The CEO made some interesting comments in this regard in their earnings call. I believe the recent drop in price may be an opportunity. For further details see: Aurinia Buyout Chatter: CEO Says To 'Read Betwee...